Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 71.55B | 71.55B | 72.57B | 83.66B | 88.13B | 99.69B |
Gross Profit | 17.24B | 17.24B | 17.96B | 20.58B | 21.47B | 25.09B |
EBITDA | 3.77B | 2.97B | 2.39B | 858.00M | 3.51B | 7.14B |
Net Income | 405.00M | 405.00M | -1.60B | 78.00M | -826.00M | 2.86B |
Balance Sheet | ||||||
Total Assets | 55.97B | 55.97B | 60.72B | 64.12B | 65.75B | 69.23B |
Cash, Cash Equivalents and Short-Term Investments | 13.22B | 13.22B | 16.42B | 19.18B | 18.66B | 20.12B |
Total Debt | 7.32B | 7.32B | 8.38B | 7.71B | 7.38B | 8.05B |
Total Liabilities | 35.55B | 35.55B | 38.92B | 39.92B | 40.68B | 41.37B |
Stockholders Equity | 20.09B | 20.09B | 21.40B | 23.52B | 23.96B | 26.22B |
Cash Flow | ||||||
Free Cash Flow | -641.00M | 0.00 | 907.00M | 4.28B | 3.56B | 9.62B |
Operating Cash Flow | -641.00M | 0.00 | 926.00M | 4.30B | 3.58B | 9.62B |
Investing Cash Flow | -2.13B | 0.00 | -52.00M | -1.20B | 3.30B | -11.07B |
Financing Cash Flow | 360.00M | 0.00 | -1.36B | -1.99B | -3.68B | -2.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $812.91B | 38.88 | 23.69% | 0.89% | 4.23% | 38.05% | |
72 Outperform | $40.51B | 10.46 | 25.47% | 5.05% | -1.55% | -11.41% | |
68 Neutral | $406.82B | 50.83 | 27.77% | 0.54% | 8.17% | 9.92% | |
68 Neutral | $44.07B | 17.06 | 29.38% | 1.97% | -2.13% | 3.22% | |
66 Neutral | $11.96B | 20.84 | 27.58% | ― | 2.48% | 9.41% | |
56 Neutral | $2.30B | 41.09 | 1.96% | 14.67% | -2.04% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |